We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medium-sized drugmaker Eisai has transferred the marketing
rights for the Inhibace angiotensin converting enzyme inhibitor to fellow Japanese
producer Chugai Pharmaceutical.
Recent pharmaceutical sector development in Bahrain has centred on
two key areas, namely international trade agreements and the expansion of private
sector healthcare provision.
According to local studies, investment in R&D in Mexico
remains at low levels, continuing a trend begun as long ago as the first half
of the twentieth century.
Polish health authorities have lowered the price of domestically
produced insulin, while also reducing the amount reimbursed for foreign-manufactured
versions of the diabetes medicine.
As India awaits the approval of its new WTO-compliant patent legislation,
local reports suggest that the government could set up a special court to handle
the expected rise in intellectual property cases in the country.
Israeli media sources report that the government is studying a significant
concession to US authorities on its proposed changes to intellectual property
law.